Hospital Blood Testing on Deceased Patient Samples After Transfer to Authorities
No, a hospital should not perform additional blood testing on previously acquired samples from a deceased patient after the body has been transferred to authorities for official autopsy without notifying the authorities and obtaining family consent. This practice violates both ethical standards and best practices for postmortem testing, even though it may not be strictly illegal in all circumstances.
Legal Framework
While the legal landscape is nuanced, the key distinction lies in who has authority over the deceased and the samples:
- Once a body is transferred to medical examiner/coroner (ME/C) authorities for official autopsy, jurisdiction over the death investigation transfers to those authorities 1
- In the United States, ME/Cs have statutory authority to pursue testing without family consent in cases of public or medicolegal autopsies 1
- However, hospitals do not have this same statutory authority once the case is under ME/C jurisdiction
- HIPAA Privacy Rule protections may not apply to autopsy reports and may be subject to public disclosure 1
Ethical Imperatives
The 2023 ACMG guidelines establish clear ethical standards that apply to this scenario:
Family notification is essential: Although consent is not always legally required for postmortem testing, reasonable efforts should be made to notify the decedent's family (at minimum, next of kin or first-degree relatives) before conducting testing 1. This is particularly critical because:
- Genetic and other testing results can affect not only the decedent but also family members
- There may be a "duty to warn" component when testing could reveal information relevant to relatives' health 1
- Testing without notification undermines trust and respect for the deceased and their family
Research requires explicit consent: If the hospital's testing constitutes research rather than clinical care, family consent is mandatory. The National Association of Medical Examiners, NIH, and Swiss Academy of Medical Sciences all recommend obtaining consent before proceeding with secondary research on biological samples from decedents 1
Practical Considerations and Pitfalls
Jurisdictional conflicts: Performing testing without informing authorities who have assumed jurisdiction could:
- Interfere with the official death investigation
- Compromise chain of custody for samples
- Create legal liability for the hospital
- Undermine the ME/C's ability to determine cause and manner of death 1
Sample prioritization: The guidelines specify that samples saved for clinical testing should be prioritized for clinical testing 1, but this assumes proper authorization and coordination with relevant parties.
Recommended Approach
If a hospital believes additional testing is clinically indicated after transfer to authorities:
- Contact the ME/C office to discuss the clinical rationale and coordinate testing
- Notify the family about the proposed testing and its potential implications
- Obtain appropriate consent if the testing goes beyond what was originally authorized
- Document all communications with authorities and family
- Ensure testing serves a legitimate clinical purpose rather than institutional interests
The fundamental principle is transparency and respect for both legal authority and family autonomy 1. Conducting testing in secret, without knowledge of authorities or family, violates these core ethical tenets regardless of technical legal permissibility.